RxDoctor Payments Data

Randall Meredith, MD

Adult Reconstructive Orthopaedic Surgery · Augusta, GANPI 1801950712

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Smith+Nephew at 30.4% of the total. Reporting peaked in 2024 at $289 and has fallen 82.8% since, to $50 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in GA, where the typical reported total is $8,375.

$1,410in general payments, 2019–2025

Across 56 payments — averaging $25.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$428
  • Johnson & Johnson$397
  • Amgen$273
  • Fidia Pharma USA Inc.$115
  • Heron Therapeutics, Inc.$27
  • Moximed, Inc$27
  • plus $142 from 8 others

What the payments were for

  • Food & beverage$1,410100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,410 in reported general payments places this provider in the 25th percentile of 23 adult reconstructive orthopaedic surgery providers in Georgia.

See all adult reconstructive orthopaedic surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$397,657
Medicare patients
602
Services billed
2,174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib193$5,043
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen401$3,974
Ondansetron Hcl324$2,033
Meloxicam441$1,081
Diclofenac Sodium61$888
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen92$798
Gabapentin88$637
Pregabalin31$472
Amoxicillin282$428
Ibuprofen35$259
Naproxen23$197
Cephalexin95$180
Oxycodone Hcl15$140
Tramadol Hcl72$126
Dexamethasone12$112

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →